Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2025 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics Announces Randomization of First Patient in Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD

ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
October 09, 2025 10:35 ET | Source: Alkeus Pharmaceuticals

Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando

CAMBRIDGE, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today...
September 09, 2025 10:05 ET | Source: Research and Markets

North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL

Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "North America Intraocular Lens Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ...
July 14, 2025 05:20 ET | Source: Research and Markets

Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 | Advancements in Anti-VEGF Therapies Driving Progress in Treatments

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Myopic Macular Degeneration Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report...
June 26, 2025 06:12 ET | Source: Research and Markets

Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements

Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering.This report describes and...
May 15, 2025 09:32 ET | Source: Research and Markets

Age-Related Macular Degeneration (AMD) Market Forecast Report and Company Analysis 2025-2033 Featuring Hoffmann - La Roche, Bayer, Abbvie, GSK, Novartis, Regeneron Pharma, Bausch, Alimera Science

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ...
May 06, 2025 20:00 ET | Source: Optigo Biotherapeutics Inc.

Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference

Optigo Bio Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at ARVO 2025
March 06, 2025 06:00 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies to Participate at the 37th Annual Roth Conference

RetinalGenix Technologies to Participate at 2025 Roth Conference and will discuss patented remote monitoring high-resolution retinal imaging and biomarkers
February 20, 2025 06:30 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring

RETINALGENIX TECHNOLOGIES BREAKTHROUGH IN REAL-TIME 24/7 REMOTE OCULAR MONITORING High-Resolution Retinal Imaging Using Both Near Infrared And Green Modes
February 04, 2025 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings

ANN ARBOR, Mich., Feb. 04, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...